1. Introduction {#sec1-molecules-24-00563}
===============

*Lindera akoensis* Hayata belonging to the Lauraceae family, moreover, it is an endemic species widely distributed in central and southern Taiwan. Traditionally it has been used by local residents to treat various inflammation symptom \[[@B1-molecules-24-00563]\]. The genus *Lindera* has shown many bioactivities, including antitumor \[[@B2-molecules-24-00563],[@B3-molecules-24-00563],[@B4-molecules-24-00563]\], anti-inflammatory \[[@B5-molecules-24-00563],[@B6-molecules-24-00563]\] and antibacterial \[[@B7-molecules-24-00563],[@B8-molecules-24-00563]\] properties in previous literature reports. Previous phytochemical research of the genus *Lindera* revealed an abundance of butalactones \[[@B8-molecules-24-00563],[@B9-molecules-24-00563],[@B10-molecules-24-00563]\], sesquiterpenes \[[@B11-molecules-24-00563]\] and flavonoids \[[@B9-molecules-24-00563],[@B12-molecules-24-00563],[@B13-molecules-24-00563]\] in this genus. In our earlier study on the aerial parts of *L. akoensis*, was explored the isolation of butanolides, flavonols, and lignans \[[@B9-molecules-24-00563]\]. In order to confirm the traditional folk usage of *L. akoensis*, this study continued our previous work on the isolation and purification of *L. akoensis* components. Six novel compounds ([Figure 1](#molecules-24-00563-f001){ref-type="fig"}) and 25 known compounds were isolated and identified. Next their anti-inflammatory activity was evaluated. Based on our experimental results, compound **1** has anti-inflammatory activity by decreasing nitric oxide (NO) production induced by lipopolysaccharide in mouse macrophage RAW264.7 cells in IC~50~ 36.3 ± 3.2 μM, having potential as a lead compound to treat symptoms of inflammation.

2. Results and Discussion {#sec2-molecules-24-00563}
=========================

Thirty one compounds were isolated and identified from aerial part of *L. akoensis* including kaempferol-3-*O*-β-*D*-4′′,6′′-di-(*E*)-*p*-coumaroylglucoside (**1**), 3′′-(*E*)-*p*-coumaroylafzelin (**2**) and 4'-*O*-methyl-2′′,4′′-di-(*E*)-*p*-coumaroylquercitrin (**3**), and three compounds that were isolated from the natural product for the first time, 3β-dodecyl-4β-hydroxy-5β-methyldihydrofuran-2-one (**4**), 2β-acetoxyclovan-9α-ol (**5**), and (1α,4β,6β)-trihydroxyeudesmane (**6**) ([Figure 1](#molecules-24-00563-f001){ref-type="fig"}) along with 25 known compounds, including two monoterpenoids, 17 sesquiterpenoids, and six steroids. Their structures were elucidated by ESI-MS, UV, IR, 1D and 2D NMR spectrometry and comparisons with data from the literature.

Kaempferol-3-*O*-β-*D*-4′′,6′′-di-(*E*)-*p*-coumaroylglucoside (**1**) was isolated as a pale yellow solid. The IR spectrum showed the presence of hydroxyl (3240 cm^−1^) and carbonyl groups (1651 cm^−1^). Four structural units were observed in the 2D-NMR spectrum: two (*E*)-*p*-coumaroyls, glucose and a kaempferol nucleus ([Figure 2](#molecules-24-00563-f002){ref-type="fig"}). Two A~2~X~2~ coupling systems (δ~H~ 7.74 (2H, *d*, *J*= 8.5 Hz, H-5′′′, -9′′′), 6.81 (2H, *d*, *J*= 8.5 Hz, H-6′′′, -8′′′) and 7.26 (2H, *d*, *J*= 8.5 Hz, H-5′′′′, -9′′′′), 6.80 (2H, *d*, *J*= 8.5 Hz, H-6′′′′, -8′′′′)\] and two olefinic protons δ~H~ 6.41, 7.68 (each 1H, *d*, *J*= 15.9 Hz, H-2′′′, -3′′′) and δ~H~ 6.06, 7.39 (each 1H, *d*, *J*= 15.9 Hz, H-2′′′′, -3′′′′) in the ^1^H-NMR spectrum indicated the occurrence of two (*E*)-*p*-coumaroyl group. A down-shifted chemical shift δ~H~ 5.18 (1H, *t*, *J*= 9.4 Hz) appeared on C-4′′ that conjecturing esterified on H-4′′ position, the other *(E)*-*p*-coumaroyl group replaced on CH~2~OH of glucose corroborated by HMBC spectrum. The characteristic kaempferol signals observed in the ^1^H-NMR are consistent with the literature \[[@B14-molecules-24-00563]\], the only difference being the fact that the H-3 proton was not detected and the ^13^C-NMR signal of C-3 (δ~C~ 135.4) was more down-shifted than the C-3 of apigenin (δ~C~ 103.2) furthermore, a significant HMBC relationship of H-1′′ to C-3 was detected, so through the above evidence, the glucose-kaempferol linkage was presumed to be in a C-3-O-C-1′′ configuration. The axial-axial coupling constant (H-1′′ and -2′′, *J*= 7.8 Hz) and DEPT-135 signal of secondary carbon (C-6′′, δ~C~ 64.4) were observed, supporting the existence of β-glucose. Accordingly, the structure of **1** was elucidated as kaempferol-3-*O*-β-*D*-4′′,6′′-di-(*E*)-*p*-coumaroylglucoside, and named linderakoside F as shown in [Figure 1](#molecules-24-00563-f001){ref-type="fig"}.

3′′-(*E*)-*p*-Coumaroylafzelin (**2**) was isolated as a pale yellow solid. The IR spectrum showed the presence of hydroxyl (3431 cm^−1^) and carbonyl groups (1655 cm^−1^). Three constituents of the structure were observed---(*E*)-*p*-coumaroyl, rhamnose and kaempferol---through 2D-NMR spectrum ([Figure 2](#molecules-24-00563-f002){ref-type="fig"}). A typical methyl ^1^H-NMR signal of rhamnose δ~H~ 0.93 (3H, *d*, *J*= 5.5 Hz), different from 4′-*O*-methyl-4′′-(*E*)-*p*-coumaroylafzelin and 4′′-(*Z*)-*p*-coumaroylafzelin in our previous research \[[@B9-molecules-24-00563]\]. The steric hindrance effect between the esterification on C-3′′ and ketone of flavone, the ^1^H-NMR signal of the methyl group (H-6′′) was down-shifted at δ~H~ 0.97 (3H, *d*, *J*= 5.5 Hz), deshielded by the ketone and the aromatic flavone ring, that demonstrated the *p*-coumaroyl position was different from 4′-*O*-methyl-4′′-*(E)*-*p*-coumaroylafzelin and 4′′-(*Z*)-*p*-coumaroylafzelin. An A~2~X~2~ coupling system at δ~H~ 7.48 (2H, *d*, *J*= 8.7 Hz, H-5′′′, -9′′′) and δ~H~ 6.81 (2H, *d*, *J*= 8.7 Hz, H-6′′′, -8′′′), as well as an olefinic proton signals at δ~H~ 6.43 and 7.72 (each 1H, *d*, *J*= 15.7 Hz, H-2′′′, -3′′′) could be observed suggesting the presence of an (*E*)-*p*-coumaroyl moiety. The α-rhamnose moiety was confirmed by the small axial- equatorial coupling constant (H-1′′ and -2′′, *brs*). Comparing with our previous studies \[[@B12-molecules-24-00563]\], furthermore the HMBC relationship of H-1′′ to C-3 existed, so the the rhamnose-kaempferol linkage was in a C-3-O-C-1′′ configuration that was confirmed by ^13^C-NMR. Based on the above deduction, **2** was designated to be a new compound, 3′′-(*E*)-*p*-coumaroylafzelin, as shown in [Figure 1](#molecules-24-00563-f001){ref-type="fig"}, and named linderakoside G.

4′-*O*-Methyl-2′′,4′′-di-(*E*)-*p*-coumaroylquercitrin (**3**) was a pale yellow solid. The IR spectrum showed the presence of hydroxyl (3421 cm^−1^) and carbonyl group (1649 cm^−1^). Four parts of the structure were observed, two (*E*)-*p*-coumaroyls, rhamnose and tamarixetin through the 2D-NMR spectrum ([Figure 2](#molecules-24-00563-f002){ref-type="fig"}.). A typical methyl ^1^H-NMR signal of rhamnose appeared at δ~H~ 0.85 (3H, *d*, *J*= 6.2 Hz). According to the literature \[[@B15-molecules-24-00563]\], the methyl signal should be at δ~H~ 0.95 if the --OH on the rhamnose was not esterified, and the methyl signal was high-shifted in position 4′′ confirmining the esterfication. Two A~2~X~2~ coupling system (δ~H~ 7.50 (2H, *d*, *J*= 8.6 Hz, H-5′′′, -9′′′), 6.82 (2H, *d*, *J*= 8.6 Hz, H-6′′′, -8′′′) and 7.50 (2H, *d*, *J*= 8.6 Hz, H-5′′′′, -9′′′′), 6.85 (2H, *d*, *J*= 8.6, H-6′′′′, -8′′′′)\] and two olefinic protons δ~H~ 6.27, 7.55 (each 1H, *d*, *J*= 16.0 Hz, H-2′′′, -3′′′) and δ~H~ 6.42, 7.68 (each 1H, *d*, *J*= 16.0 Hz, H-2′′′′, -3′′′′) in the ^1^H-NMR spectrum indicated the occurrence of two (*E*)-*p*-coumaroyl group. This structure was similar to linderakoside E identified in our previous work \[[@B12-molecules-24-00563]\], with a relatively downfield chemical shift on H-2′′ δ~H~ 5.55 (1H, *dd*, *J*= 3.4, 1.7 Hz) and H-4′′ δ~H~ 4.97 (1H, *t*, *J*= 9.8 Hz), that indicated esterification on these positions. Similar to **2**, the rhamnose-kaempferol linkage was in a C-3-O-C-1′′ configuration that was confirmed by ^13^C-NMR. A methoxy signal δ~H~ 3.87 (3H, s, OMe) was observed, with a significant NOESY correlation with H-5′ δ~H~ 7.15 (1H, *d*, *J*= 8.9 Hz) and obviously HMBC correlation with C-4′ δ~C~ 152.0, thence the position was determined. The α-rhamnose moiety was confirmed by small axial-equatorial coupling constant (H-1′′ and -2′′, *J*= 1.6 Hz). Based on the above deduction, **3** was designated to be the new compound 4′-*O*-methyl-2′′,4′′-di-(*E*)-*p*-coumaroylquercitrin, and named linderakoside H, as shown in [Figure 1](#molecules-24-00563-f001){ref-type="fig"}.

3β-Dodecyl-4β-hydroxy-5β-methyldihydrofuran-2-one (**4**) was isolated as a colorless solid (\[α\]^2^°~D~ ± 0° (c = 0.8, CHCl~3~)). Three ^1^H-NMR signals (H-3, -4, -5 δ~H~ 2.55 (1H, *m*), 4.30 (*dd*, *J* = 4.6, 3.0 Hz), 4.44 (*qd*, *J* = 6.4, 3.0 Hz)) were similar to those of 3β-((*E*)-dodec-1-enyl)-4β-hydroxy-5β-methyl- dihydrofuran-2-one and 3α-((*E*)-dodec-1-enyl)-4β-hydroxy-5β-methyldihydrofuran-2-one in our previous work \[[@B9-molecules-24-00563],[@B10-molecules-24-00563]\]. Compound **4** has a *cis*-relationship between H-4 and -5 according to the literature comparison \[[@B16-molecules-24-00563]\]. Eleven CH~2~-group signals were observed, where δ~H~ 1.23 (22H, *m*), one of two methyl signals δ~H~ 1.41 (3H, *d*, *J*= 6.4 Hz) was down-shifted because the influences of the --OH and lactone moiety, another methyl δ~H~ 0.87 (3H, *t*, *J*= 7.2 Hz) was typical of a -CH~2~ chain-end ([Table S1](#app1-molecules-24-00563){ref-type="app"}). This compound was not described in natural product before, although Lee et al obtained it by hydrogenating 3-epilitsenolide D2 in 2001 \[[@B16-molecules-24-00563]\].

2β-Acetoxyclovan-9α-ol (**5**) was isolated as a colorless oil, with the molecular formula C~17~H~28~O~3~ from the HR-EI-MS (*m*/*z* 280.2027 \[M\]^+^, calcd 280.2024). The IR spectrum showed the presence of hydroxyl (3450 cm^−1^) and carbonyl groups (1738 cm^−1^). Three singlet methyl signals in the ^1^H-NMR (δ~H~ 0.89, 1.03, 0.93, each 3H, *s,* H-13, -14, -15) were characteristic of a clovane skeleton ([Table S1](#app1-molecules-24-00563){ref-type="app"}.). A typical acetyl group carbonyl was observed at δ~C~ 171.0 and δ~H~ 2.02 (3H, *s*). The structure of compound **5** was similar to that of clovandiol (**16**) \[[@B17-molecules-24-00563]\] that was isolated in this work, the only difference was δ~H~ 4.83 (1H, *dd*, *J*= 8.7, 5.9 Hz) of H-4 was down shifted more than the H-4 of clovandiol (δ~H~ 3.79, 1H, *dd*, *J*= 10.5, 5.5 Hz), thence the acetyl group is speculated to be linked at this position, and the significant HMBC relationship of H-2/C-1' confirmed this. This work is the first to describe the structure **5** in a natural product. Heymann, et al. previously obtained it by acetylating clovandiol in 1994 \[[@B18-molecules-24-00563]\]. (1α,4β,6β)-Trihydroxyeudesmane (**6**) was isolated as colorless needle-like crystals, with the molecular formula C~15~H~28~O~3~ from HR-EI-MS (*m*/*z* 256.2029 \[M\]^+^, calcd 256.2010). The absolute stereo configuration of **6** was solved by X-ray single crystal diffraction ([Figure S1](#app1-molecules-24-00563){ref-type="app"}). The IR spectrum showed the presence of a hydroxyl (3238 cm^−1^) group. The ^13^C-NMR and DEPT spectrum showed compound **6** had a eudesmane skeleton ([Table S2](#app1-molecules-24-00563){ref-type="app"}.). Two isopropyl methyls (δ~H~ 0.92, 1.09, each 3H, *d*, *J*= 6.6 Hz, H-13, -12), one down-shifted methyl (δ~H~ 1.34, 3H, *s*, H-15) affected by the --OH, one relatively high-shifted methyl (δ~H~ 0.94, 3H, *s*, H-14), and two relatively down-shifted signals affected by the --OH (δ~H~ 3.32, 1H, *m*, H-1, 4.33, 1H, *dd*, *J*= 11.2, 4.4 Hz, H-6) were observed in the ^1^H-NMR ([Table S1](#app1-molecules-24-00563){ref-type="app"}). The relative stereo configuration was decided by the NOESY spectrum, H-6/H-14/H-15 were in an axial position as defined by their significant NOESY correlations with each other. The significant correlation of H-5/H-1, -12, and -13, and the small coupling constant (4.4 Hz) between H-6 and H-7 decided the relative stereo configuration of H-1, -5, and the isopropyl. According to the literature, compound **6** was never reported as a natural product, but it was prepared by hydrolysis of pumilaside A with hesperidinase by Kitajima et al. in 2000 \[[@B19-molecules-24-00563]\].

The 25 known compounds, including two monoterpenes, (*E*)-6-hydroxy-2,6-dimethylocta-2,7- dienoic acid (**7**) \[[@B20-molecules-24-00563]\] and *trans*-sobrerol (**8**) \[[@B21-molecules-24-00563]\], seventeen sesquiterpenes: teucladiol (**9**) \[[@B22-molecules-24-00563]\], globulol (**10**) \[[@B23-molecules-24-00563]\], β-dictyopterol (**11**) \[[@B24-molecules-24-00563]\], 4β,10α-aromadendranediol-10-methyl ether (**12**) \[[@B25-molecules-24-00563]\], 4α,10β- alloaromadendranediol-10-methyl ether (**13**) \[[@B25-molecules-24-00563]\], 4β,10α-aromadendranediol (**14**) \[[@B26-molecules-24-00563]\], 4α,10β- alloaromadendranediol (**15**) \[[@B25-molecules-24-00563]\], clovandiol (**16**) \[[@B17-molecules-24-00563]\], caryophyllenol-II (**17**) \[[@B18-molecules-24-00563]\], humulene diepoxide A (**18**) \[[@B18-molecules-24-00563]\], isocaryolanediol (**19**) \[[@B18-molecules-24-00563]\], β-caryophyllene-8,9-oxide (**20**) \[[@B18-molecules-24-00563]\], kobusone (**21**) \[[@B18-molecules-24-00563]\], 7,8-epoxy-1(12)-caryophyllene-9α-ol (**22**) \[[@B18-molecules-24-00563]\], 8β-hydroxy-1(12)-caryophyllene (**23**) \[[@B27-molecules-24-00563]\], 2β-methoxyclovan-9α-ol (**24**) \[[@B28-molecules-24-00563]\] and 8,9-dihydroxy-1(12)caryophyllene (**25**) \[[@B29-molecules-24-00563]\] and six steroids, β-sitosterol (**26**) \[[@B30-molecules-24-00563]\], 5-stigmasten-3β,7β-diol (**27**) \[[@B31-molecules-24-00563]\], 5-stigmasten-3β,7α-diol (**28**) \[[@B31-molecules-24-00563]\], 5α,8α- epidioxy-24-methylcholesta-6,9,22-trien-3β-ol (**29**) \[[@B32-molecules-24-00563]\], 5α,8α-epidioxy-24-methylcholesta- 6,22- dien-3β-ol (**30**) \[[@B33-molecules-24-00563]\], and 3β-hydroxystigmast-5-en-7-one (**31**) \[[@B34-molecules-24-00563]\] were identified by comparison of their physical and reported spectroscopic data.

Caffeic acid is an effective anti-inflammatory substance. According to the literature \[[@B35-molecules-24-00563],[@B36-molecules-24-00563],[@B37-molecules-24-00563],[@B38-molecules-24-00563]\], it inhibits inflammatory responses in many ways, including nitric oxide (NO) produced by various induction pathways, therefore the anti-inflammatory evaluation in this work used caffeic acid as positive control. linderakoside F (1) showed *in vitro* anti-inflammatory activity since it decrease the LPS-stimulated production of nitrite in RAW264.7 cell, with the IC~50~ value 36.3 ± 3.2 μM a lot better than caffeic acid (162.8 ± 5.6 μM), in addition, they have no obvious cytotoxicity at the concentration of the experiment ([Figure 3](#molecules-24-00563-f003){ref-type="fig"}). Unfortunately, the weights of linderakoside G-H (2-3) was too small to evaluate their anti-inflammatory activity.

3. Experimental Section {#sec3-molecules-24-00563}
=======================

3.1. General Methods {#sec3dot1-molecules-24-00563}
--------------------

The following instruments were used for obtaining physical and spectroscopic data: optical rotations P-1020 digital polarimeter (JASCO, Kyoto, Japan); IR spectra, IR Prestige-21 Fourier transform infrared specctrometer (Shimadzu, Kyoto, Japan); UV spectrum, Shimadzu Pharmaspec-1700 UV-Visible spectrophotometer; HR-ESI-MS spectra, LCQ ion-trap mass spectrometer (Finnigan, Waltham, MA , USA); melting point, MP-J3 (Yanaco, Kyoto, Japan); and ^1^H- and ^13^C-NMR spectra, DRX- 400 at 400 and 100 MHz and 500 FT-NMR spectrometer at 500 and 125 MHz, respectively (Bruker, Bremen, Germany) with TMS as an internal standard. Silica gel column chromatography was performed on silica gel (70 - 230 mesh, Merck, Darmstadt, Germany). HPLC was performed on a Shimadzu LC-6A apparatus equipped with an IOTA-2 RI-detector. A Phenomenex Luna silica (Φ 250 × 10 mm column) was used for preparative purposes (flow rate: 2.00 mL/min). Aluminum pre-coated silica gel (Merck, Kieselgel 60 F~254~) were used for TLC monitoring with visualization by spraying with a 10% solution of H~2~SO~4~ in ethanol and heating to approximately 150°C on a hotplate.

The following instruments were used for obtaining physical and spectroscopic data: optical rotations P-1020 digital polarimeter (JASCO, Kyoto, Japan); IR spectra, IR Prestige-21 Fourier transform infrared specctrometer (Shimadzu, Kyoto, Japan); UV spectrum, Shimadzu Pharmaspec-1700 UV-Visible spectrophotometer; HR-ESI-MS spectra, LCQ ion-trap mass spectrometer (Finnigan, Waltham, MA , USA); melting point, MP-J3 (Yanaco, Kyoto, Japan); and ^1^H- and ^13^C-NMR spectra, DRX- 400 at 400 and 100 MHz and 500 FT-NMR spectrometer at 500 and 125 MHz, respectively (Bruker, Bremen, Germany) with TMS as an internal standard. Silica gel column chromatography was performed on silica gel (70 - 230 mesh, Merck, Darmstadt, Germany). HPLC was performed on a Shimadzu LC-6A apparatus equipped with an IOTA-2 RI-detector. A Phenomenex Luna silica (Φ 250 × 10 mm column) was used for preparative purposes (flow rate: 2.00 mL/min). Aluminum pre-coated silica gel (Merck, Kieselgel 60 F~254~) were used for TLC monitoring with visualization by spraying with a 10% solution of H~2~SO~4~ in ethanol and heating to approximately 150°C on a hotplate.

3.2. Plant Material {#sec3dot2-molecules-24-00563}
-------------------

The aerial part of *L. akoensis* was collected in Taichung, Taiwan, in July, 2008. This material was identified by Prof. Yen-Hsueh Tseng, Department of Forestry, National Chung Hsing University, Taichung, Taiwan. A voucher specimen (CMU2008-06-LA) was deposited in the School of Pharmacy, China Medical University.

3.3. Extraction and Isolation {#sec3dot3-molecules-24-00563}
-----------------------------

The dried aerial part of *L. akoensis* (dry weight 5.9 kg) was extracted with 95% ethanol for 7 days (20 L, three times). The dried crude extract (337.8 g) was suspended in H~2~O and partitioned successively with EtOAc and *n*-BuOH. The EtOAc layer was evaporated in vacuo to yield a residue (127.8 g) that was subjected to silica gel column chromatography (particle size 70--230 mesh) and eluted with a gradient of increasing polarity with solvent of *n*-hexane/EtOAc solvent (99:1/0:100) to give 21 fractions. Fraction 16 (7.15 g) was separated using semi-preparative HPLC with the conditions (CH~2~Cl~2~/EtOAc, *v*/*v* 6:4; *n*-hexane/acetone v/v 7:3; *n*-hexane/EtOAc *v*/*v* 1:1) alternately to afford pure **1** (143.7 mg), **2** (1.1 mg), **3** (2.0 mg), and **8** (85.5 mg). Fraction 15 (1.23 g) was separated using semi-preparative HPLC with the conditions (CH~2~Cl~2~/EtOAc, *v*/*v* 6 : 4; *n*-hexane/acetone *v*/*v* 7:3; *n*-hexane/EtOAc *v*/*v* 1:1) alternately to afford pure **4** (16.9 mg), **6** (36.2 mg), **7** (71.3 mg), **15** (12.8 mg), **16** (47.7 mg), **19** (8.5 mg), **27** (46.3 mg), and **28** (55.1 mg). Fraction 11 (5.08 g) was separated using semi-preparative HPLC with the conditions (CH~2~Cl~2~/EtOAc, *v*/*v* 7:3; *n*-hexane/acetone *v*/*v* 4:1; *n*-hexane/EtOAc *v*/*v* 3:2) alternately to afford pure **5** (12.7 mg), **9** (17.2 mg), **12** (14.3 mg), **13** (16.6 mg), **14** (10.9 mg), **22** (10.8 mg), **24** (18.8 mg), and **25** (7.6 mg). Fraction 8 (10.84 g) was separated using semi-preparative HPLC with the conditions (CH~2~Cl~2~/EtOAc, *v*/*v* 4:1; *n*-hexane/acetone *v*/*v* 9:1; *n*-hexane/EtOAc *v*/*v* 7:3) alternately to afford pure **10** (9.8 mg), **11** (9.1 mg), **17** (7.2 mg), **18** (6.4 mg), **21** (9.3 mg), **23** (8.3 mg), **26** (873.5 mg), **29** (15.5 mg), and **30** (17.3 mg). Fraction 4 (0.87 g) was separated using semi-preparative HPLC with the conditions (CHCl~3~/EtOAc, *v*/*v* 8:1; *n*-hexane/acetone *v*/*v* 10:1; *n*-hexane/EtOAc *v*/*v* 4:1) alternately to afford pure **31** (62.2 mg). Fraction 3 (10.03 g) was separated using semi-preparative HPLC with the conditions (CHCl~3~/EtOAc, *v*/*v* 9:1; *n*-hexane/acetone *v*/*v* 12:1; *n*-hexane/EtOAc *v*/*v* 5:1) alternately to afford pure **20** (10.2 mg).

3.4. Linderakoside F *(**1**)* {#sec3dot4-molecules-24-00563}
------------------------------

Pale yellow solid; mp: 213 °C; \[α\]^20^~D~-54.6° (*c* = 8.9, CH~3~OH); IR (film) ν~max~: 3240, 2936, 1651, 1605, 1512, and 1173 cm^−1^; UV ν~max~ (MeOH) nm (log *ε*): 314 (4.79), 248 (4.30) and, 210 (4.70); ^1^H-NMR (500 MHz, methanol-*d*~4~): [Table 1](#molecules-24-00563-t001){ref-type="table"}; ^13^C-NMR (125 MHz, methanol-*d*~4~): [Table 2](#molecules-24-00563-t002){ref-type="table"}; and positive-ion HR-ESI-MS: *m/z* 763.1630 \[M + Na\]^+^ (calcd for C~39~H~32~O~15~Na: 763.1633).

3.5. Linderakoside G *(**2**)* {#sec3dot5-molecules-24-00563}
------------------------------

Pale yellow solid; mp: 162 °C; \[α\]^20^~D~-149.1° (*c* = 0.6, CH~3~OH); IR (film) ν~max~: 3431, 1651, 1618 and 1171 cm^−1^; UV ν~max~ (MeOH) nm (log *ε*): 314 (4.53), 276 (4.40), 267 (4.46), 246 (4.22), and 210 (4.56); ^1^H-NMR (500 MHz, methanol-*d*~4~): [Table 1](#molecules-24-00563-t001){ref-type="table"}; ^13^C-NMR (125 MHz, methanol-*d*~4~): [Table 2](#molecules-24-00563-t002){ref-type="table"}; and positive-ion HR-ESI-MS: *m/z* 601.1317 \[M + Na\]^+^ (calcd for C~30~H~26~O~12~Na: 601.1316).

3.6. Linderakoside H *(**3**)* {#sec3dot6-molecules-24-00563}
------------------------------

Pale yellow solid; mp: 221 °C; \[α\]^20^~D~-166.2° (*c* = 0.3, CH~3~OH); IR (film) ν~max~: 3421, 2933, 1649, 1605, 1512, and 1169 cm^−1^; UV ν~max~ (MeOH) nm (log *ε*): 315 (4.70), 274 (4.47), 267 (4.49), 246 (4.34), and 210 (4.70); ^1^H-NMR (500 MHz, methanol-*d*~4~): [Table 1](#molecules-24-00563-t001){ref-type="table"}; ^13^C-NMR (125 MHz, methanol-*d*~4~): [Table 2](#molecules-24-00563-t002){ref-type="table"}; and positive-ion HR-ESI-MS: *m/z* 777.1650 \[M + Na\]^+^ (calcd for C~40~H~34~O~15~Na: 777.1653).

3.7. Bioactivity Assays {#sec3dot7-molecules-24-00563}
-----------------------

The assays of evaluating nitric oxide (NO) production and cell viability on RAW264.7 cells were followed our studies before \[[@B9-molecules-24-00563],[@B10-molecules-24-00563]\] and consulted literature \[[@B39-molecules-24-00563]\]. RAW264.7 cells were seeded at a density of 5 × 10^4^ cells/well in 96-well plates for 12 h. Cells were treated with linderakoside F (**1**) in the presence of LPS (100 ng/mL) for 24 hours. Supernatants were collected and NO levels were determined using the Greiss reagent. Each of 100 μL of supernatant was mixed with 100 μL of Griess reagent (0.1% *N*-(1-naphthyl)-ethylenediamine dihydrochloride, 1% sulfanilamide, and 5% phosphoric acid) then incubated for 5 min at room temperature. The absorbance of the mixture was measured at 540 nm using a microplate reader (SpectraMax^®^ M2e, Molecular Devices, Sunnyvale, CA, USA). Culture media were used as blanks and the nitrite levels were determined by using a standard curve obtained from sodium nitrite (0--125 μM).

4. Conclusions {#sec4-molecules-24-00563}
==============

Despite being an endemic species of Lauraceae in Taiwan, there are not many reports yet on the phytochemistry and bioactivities of *L. akoensis*. Traditionally, *L. akoensis* is only used for ornamental purposes and some inflammation treatments. This study obtained three new flavonol acylglycosides, linderakosides F-H (compounds **1**--**3**) and three components **4**--**6** isolated from a natural product that first time, along with 25 known compounds, including two monoterpenoids **7**--**8**, 17 sesquiterpenoids **9**--**25**, and six steroids **26**--**31** which were isolated from this plant for the first time. Linderakoside F (**1**) displayed potential anti-inflammatory activity, with an IC~50~ value of 36.3 ± 3.2 μM. In this work, we discovered active components as potential lead compounds and additionally provided a scientific basis for the drug use of *L. akoensis*.

The measurement of X-ray diffraction and HRESI-MS were made using Bruker D8 VENTURE and JEOL JEM-2010 instruments at Department of Chemistry of National Chung Hsing University. We also thank the Longyan University and Tsuzuki Institute for Traditional Medicine for financial support.

**Sample Availability:** Samples of the compounds are available from the authors.

The following are available online, Figure S1: X-ray crystallographic structure of compound 6, Table S1: ^1^H-NMR spectroscopic data of compounds **4**--**6** (in CDCl~3~, 400 MHz), Table S2: 13C-NMR spectroscopic data of compounds **5**--**6** (in CDCl~3~, 100 MHz).
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Click here for additional data file.
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![Compounds **1**--**6** isolated from the aerial part of *L. akoensis.*](molecules-24-00563-g001){#molecules-24-00563-f001}

![Selected key HMBC, COSY, and NOESY correlations of compounds **1**--**3**.](molecules-24-00563-g002){#molecules-24-00563-f002}

![(**A**) Cytotoxicity of linderakoside F and caffeic acid in LPS-stimulated RAW264.7 cells. Cells were treated with linderakoside F at 3.75, 7.5, 15, 30 μM and caffeic acid at 35, 70, 140, 280 μM for 24 h, and cell viability was assayed by the MTT assay. Data were expressed as the means ± S.D. of three respectively experiments. (**B**) Effect of linderakoside F (**1**) and caffeic acid on NO production in LPS-stimulated RAW264.7 cells. Cells were incubated with LPS (100 ng/mL) in the presence of following doses at 3.75, 7.5, 15, 30 μM and 35, 70, 140, 280 μM of linderakoside F (**1**) and caffeic acid respectively for 24 h. Values were expressed as mean ± S.D. of three replicates. Mean with different letters represent significantly different (*p* \< 0.05) by Scheffé's method.](molecules-24-00563-g003){#molecules-24-00563-f003}
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###### 

^1^H-NMR spectroscopic data of compounds **1**--**3** (in methanol-*d*~4~, 500 MHz) ^a^.

  ------------------------------------------------------------------------------------------------------------------
  Position   Linderakoside F (1)                 Linderakoside G (2)               Linderakoside H (3)
  ---------- ----------------------------------- --------------------------------- ---------------------------------
  6          6.12 (1H, *br s*)                   6.21 (1H, *br s*)                 6.22 (1H, *d*, *J* = 2.0)

  8          6.26 (1H, *br s*)                   6.40 (1H, *br s*)                 6.39 (1H, *d*, *J* = 2.0)

  2′         7.97 (1H, *d*, *J* = 8.5)           7.84 (1H, *d*, *J* = 8.8)         7.40 (1H, *s*)

  3′         6.82 (1H, *d*, *J* = 8.5)           6.97 (1H, *d*, *J* = 8.8)         \-

  5′         6.82 (1H, *d*, *J* = 8.5)           6.97 (1H, *d*, *J* = 8.8)         7.15 (1H, *d*, *J* = 8.9)

  6′         7.97 (1H, *d*, *J* = 8.5)           7.84 (1H, *d*, *J* = 8.8)         7.41 (1H, *d*, *J* = 8.9)

  1′′        5.36 (1H, *d*, *J* = 7.8)           5.47 (1H, *br s*)                 5.71 (1H, *d*, *J* = 1.6)

  2′′        3.73 (1H, *dd*, *J* = 9.4, 7.8)     4.44 (1H, *br s*)                 5.55 (1H, *dd*, *J* = 3.4, 1.6)

  3′′        3.59 (1H, *t*, *J* = 9.4)           5.13 (1H, *m*)                    4.17 (1H, *dd*, *J* = 9.8, 1.6)

  4′′        5.18 (1H, *t*, *J* = 9.4)           3.61 (1H, *t*, *J* = 9.3)         4.97 (1H, *t*, *J* = 9.8)

  5′′        3.67 (1H, *m*)                      3.44 (1H, *qd*, *J* = 5.5, 9.3)   3.31 (1H, *qd*, *J* = 6.2, 9.8)

  6′′        4.25 (1H, *dd*, *J* = 12.5, 6.5)\   0.97 (3H, *d*, *J* = 5.5)         0.85 (3H, *d*, *J* = 6.2)
             4.34 (1H, *d*, *J* = 12.5)                                            

  2′′′       6.41 (1H, *d*, *J* = 15.9)          6.43 (1H, *d*, *J* = 15.7)        6.30 (1H, *d*, *J* = 16.0)

  3′′′       7.68 (1H, *d*, *J* = 15.9)          7.72 (1H, *d*, *J* = 15.7)        7.60 (1H, *d*, *J* = 16.0)

  5′′′       7.44 (1H, *d*, *J*= 8.5)            7.48 (1H, *d*, *J* = 8.7)         7.50 (1H, *d*, *J* = 8.6)

  6′′′       6.81 (1H, *d*, *J* = 8.5)           6.81 (1H, *d*, *J* = 8.7)         6.82 (1H, *d*, *J* = 8.6)

  8′′′       6.81 (1H, *d*, *J* = 8.5)           6.81 (1H, *d*, *J* = 8.7)         6.82 (1H, *d*, *J* = 8.6)

  9′′′       7.44 (1H, *d*, *J* = 8.5)           7.48 (1H, *d*, *J* = 8.7)         7.50 (1H, *d*, *J* = 8.6)

  2′′′′      6.06 (1H, *d*, *J* = 15.9)          \-                                6.42 (1H, *d*, *J* = 16.0)

  3′′′′      7.39 (1H, *d*, *J* = 15.9)          \-                                7.70 (1H, *d*, *J*= 16.0)

  5′′′′      7.26 (1H, *J* = 8.5)                \-                                7.50 (1H, *d*, *J* = 8.6)

  6′′′′      6.80 (1H, *J* = 8.5)                \-                                6.85 (1H, *d*, *J* = 8.6)

  8′′′′      6.80 (1H, *J* = 8.5)                \-                                6.85 (1H, *d*, *J* = 8.6)

  9′′′′      7.26 (1H, *J* = 8.5)                \-                                7.50 (1H, *d*, *J* = 8.6)

  OCH~3~     \-                                  \-                                3.87 (3H, *s*)
  ------------------------------------------------------------------------------------------------------------------

^a^ The chemical shifts are expressed in δ ppm. The coupling constants (*J*) are expressed in Hz.
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###### 

^13^C-NMR spectroscopic data of compounds **1**--**3** (in methanol-*d*~4~, 125 MHz).

  Position   Linderakoside F (1)   Linderakoside G (2)   Linderakoside H (3)
  ---------- --------------------- --------------------- ---------------------
  2          159.3                 159.6                 159.4
  3          135.4                 136.2                 134.1
  4          179.3                 176.5                 179.6
  4a         105.7                 103.2                 100.2
  5          158.4                 158.8                 158.8
  6          100.1                 100.1                 100.2
  7          165.9                 166.2                 166.4
  8          95.1                  95.0                  95.1
  8a         162.9                 163.4                 163.4
  1′         122.7                 122.7                 125.0
  2′         132.4                 132.1                 131.5
  3′         117.0                 116.8                 148.1
  4′         161.2                 161.8                 152.0
  5′         117.0                 116.8                 114.9
  6′         132.4                 132.1                 131.5
  1′′        104.1                 103.2                 100.2
  2′′        74.2                  70.1                  73.1
  3′′        70.3                  75.3                  68.6
  4′′        78.9                  70.7                  74.9
  5′′        75.8                  72.4                  70.0
  6′′        64.4                  17.9                  18.0
  1′′′       169.2                 169.1                 168.7
  2′′′       115.5                 116.0                 114.8
  3′′′       146.9                 147.0                 147.6
  4′′′       127.4                 127.5                 127.3
  5′′′       131.3                 132.1                 131.5
  6′′′       116.9                 116.0                 117.0
  7′′′       161.3                 161.5                 161.6
  8′′′       116.9                 116.0                 117.0
  9′′′       131.3                 132.1                 131.5
  1′′′′      168.9                 \-                    168.4
  2′′′′      114.8                 \-                    114.9
  3′′′′      146.7                 \-                    147.6
  4′′′′      127.2                 \-                    127.3
  5′′′′      131.3                 \-                    131.5
  6′′′′      116.2                 \-                    117.0
  7′′′′      161.6                 \-                    161.6
  8′′′′      116.2                 \-                    117.0
  9′′′′      131.3                 \-                    131.5
  OCH~3~     \-                    \-                    56.7

[^1]: These authors contributed equally to this work.
